Crisantaspase Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Crisantaspase Manufacturers of Crisantaspase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Crisantaspase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 20 IU/m220 (20)As recommended.IV4.8hourly Paedriatic Dosage (20kg) 600 units/kg600 (600)As recommended.I/M100 100 (100)As recommended.I/Vdaily for 10 days after treatment with vincristine and prednisone Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Crisantaspase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Crisantaspase Back to top Manufacturers of Crisantaspase in Pakistan S.Ejazuddin Usmanco Back to top Previous Drug Generic - Next Drug Generic
Crisantaspase Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Crisantaspase Manufacturers of Crisantaspase Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Crisantaspase's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 20 IU/m220 (20)As recommended.IV4.8hourly Paedriatic Dosage (20kg) 600 units/kg600 (600)As recommended.I/M100 100 (100)As recommended.I/Vdaily for 10 days after treatment with vincristine and prednisone Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Crisantaspase is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Crisantaspase Back to top Manufacturers of Crisantaspase in Pakistan S.Ejazuddin Usmanco Back to top Previous Drug Generic - Next Drug Generic